Floaters Relief

Chelidonium Majus, Physostigma Venenosum Seed, Euphrasia Stricta,potassium Sulfate, Sodium Chloride, Phosphorus, Silicon Dioxide, Sepia Officinalis Juice

Trp Company
Human Otc Drug
NDC 17312-098

Floaters Relief also known as Chelidonium Majus, Physostigma Venenosum Seed, Euphrasia Stricta,potassium Sulfate, Sodium Chloride, Phosphorus, Silicon Dioxide, Sepia Officinalis Juice is a human otc drug labeled by 'Trp Company'. National Drug Code (NDC) number for Floaters Relief is 17312-098. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Floaters Relief drug includes Chelidonium Majus - 6 [hp_X]/mL Euphrasia Stricta - 6 [hp_X]/mL Phosphorus - 12 [hp_X]/mL Physostigma Venenosum Seed - 12 [hp_X]/mL Potassium Sulfate - 10 [hp_X]/mL Sepia Officinalis Juice - 7 [hp_X]/mL Silicon Dioxide - 12 [hp_X]/mL Sodium Chloride - 10 [hp_X]/mL . The currest status of Floaters Relief drug is Active.

Drug Information:

Drug NDC:	17312-098
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Floaters Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Chelidonium Majus, Physostigma Venenosum Seed, Euphrasia Stricta,potassium Sulfate, Sodium Chloride, Phosphorus, Silicon Dioxide, Sepia Officinalis Juice
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Trp Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	CHELIDONIUM MAJUS - 6 [hp_X]/mL EUPHRASIA STRICTA - 6 [hp_X]/mL PHOSPHORUS - 12 [hp_X]/mL PHYSOSTIGMA VENENOSUM SEED - 12 [hp_X]/mL POTASSIUM SULFATE - 10 [hp_X]/mL SEPIA OFFICINALIS JUICE - 7 [hp_X]/mL SILICON DIOXIDE - 12 [hp_X]/mL SODIUM CHLORIDE - 10 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	OPHTHALMIC
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	09 Aug, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	07 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	TRP Company
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0858961001983
UPC stands for Universal Product Code.
UNII:	7E889U5RNN C9642I91WL 27YLU75U4W CJV9E9IIOA 1K573LC5TV QDL83WN8C2 ETJ7Z6XBU4 451W47IQ8X
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:	Increased Large Intestinal Motility [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Osmotic Activity [MoA] Osmotic Laxative [EPC] Potassium Compounds [CS] Potassium Salt [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
17312-098-15	1 BOTTLE, DROPPER in 1 PACKAGE (17312-098-15) / 10 mL in 1 BOTTLE, DROPPER	09 Aug, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Eye Floaters Relief

Chelidonium Majus & more..

Liquid
TRP Company
NDC: 17312-039

Floaters Relief

Chelidonium Majus & more..

Liquid
TRP Company
NDC: 17312-098

Purpose:

Product Elements:

Floaters relief chelidonium majus, physostigma venenosum seed, euphrasia stricta,potassium sulfate, sodium chloride, phosphorus, silicon dioxide, sepia officinalis juice silicon dioxide silicon dioxide benzalkonium chloride water sodium phosphate, dibasic sodium phosphate, monobasic sepia officinalis juice sepia officinalis juice chelidonium majus chelidonium majus phosphorus phosphorus sodium chloride sodium cation potassium sulfate potassium cation euphrasia stricta euphrasia stricta physostigma venenosum seed physostigma venenosum seed

Indications and Usage:

Uses:* according to homeopathic indications these ingredients provide temporary relief from symptoms such as: â¢ floaters â¢ squiggly lines in vision â¢ irritation â¢ dark dots in vision â¢ shapes in vision â¢ dust particles in vision; after serious causes have been ruled out by a physician. *these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

Warnings:

Warnings: a physician should always be consulted to rule out serious causes. for external use only. this product is intended to complement not replace, standard medical treatment. initial worsening of symptoms may occur.

Contact lens wearers consult physician before use. to avoid contamination - do not touch tip to any surface. replace cap after every use. use within 30 days of opening. expiration date only refers to the unopened bottle. the use of this container by more than one person may spread infection.

Do Not Use:

Dosage and Administration:

Directions: â¢ suitable for adults and children ages 2 and over. children under the age of 2: consult a physician before use. squeeze 1-3 drops in the eye. use several times per day as needed. homeopathic remedies may not be effective for everyone. individual results may vary.

Stop Use:

Stop use and ask a doctor if: you experience eye pain or change in vision, continued shapes, or floaters in vision. the condition worsens. symptoms last longer than 72 hours.

Package Label Principal Display Panel:

Carton label

Further Questions:

Questions or comments? www.thereliefproducts.com, 1-888-969-6855

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.